Rialto Wealth Management’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.25K Buy
22
+11
+100% +$641 ﹤0.01% 1299
2026
Q2
$640 Buy
+11
New +$597 ﹤0.01% 1553
2025
Q3
– Sell
-15
Closed -$488 – 1768
2025
Q2
$488 Buy
+15
New +$492 ﹤0.01% 1171

Other funds holding PCVX

Rialto Wealth Management's PCVX Position: Q3 2026 in Review

Rialto Wealth Management increased its Vaxcyte (PCVX) stake by 100% in Q3 2026, buying an estimated $641 and bringing the position to 22 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

Rialto Wealth Management first reported a position in PCVX in Q2 2025 and has held it in 3 quarters since. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Rialto Wealth Management held 22 shares of Vaxcyte worth $1.25K as of Q3 2026.
  • Rialto Wealth Management bought 11 Vaxcyte shares in Q3 2026, an estimated $641.
  • Vaxcyte made up ﹤0.01% of Rialto Wealth Management's portfolio in Q3 2026, its #1299 holding.
  • Rialto Wealth Management first reported a position in Vaxcyte in Q2 2025 and has held it in 3 quarters since.
  • 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Rialto Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.